<DOC>
	<DOCNO>NCT02618967</DOCNO>
	<brief_summary>The purpose study obtain initial information safety tolerability ( effect good bad ) , pharmacokinetics ( body drug ) , pharmacodynamics ( drug body ) single dose AMG 570 .</brief_summary>
	<brief_title>Single Ascending Dose Study AMG 570 Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Lupus Erythematosus , Systemic</mesh_term>
	<criteria>Healthy determine investigator Normal clinically acceptable ECG Female subject must document nonreproductive potential Subjects must current vaccination Other inclusion criterion may apply Current chronic history liver disease History active infection History significant respiratory disorder Evidence renal disease Other exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Lupus</keyword>
	<keyword>Healthy Volunteer</keyword>
	<keyword>Safety Study</keyword>
	<keyword>Placebo Control</keyword>
	<keyword>Phase 1</keyword>
</DOC>